Skip to main content
. 2022 Oct 19;14(10):2236. doi: 10.3390/pharmaceutics14102236

Figure 1.

Figure 1

Summary of different modification strategies for EVs. (A) to increase EV production; (B) to improve nucleic acid drug loading efficiency; (C) to extend circulation time; (D) to improve targeting capability. (Created with BioRender.com, accessed on 23 August 2022).